Related Experiment Videos
Immunosuppression and modulation in liver transplantation
Jens Encke1, Waldemar Uhl, Wolfgang Stremmel
1Department of Internal Medicine IV, Gastroenterology, Hepatology, Infectious Diseases, Intoxications, University of Heidelberg, Bergheimerstrasse 58, 69115 Heidelberg, Germany. Jens_Encke@med.uni-heidelberg.de
Summary
Immunosuppressive drugs improve liver transplant outcomes but chronic rejection and side effects remain challenges. This review covers current immunosuppression strategies, rejection treatment, and complications in liver transplant patients.
Area of Science:
- Hepatology
- Transplantation immunology
- Clinical pharmacology
Background:
- Significant improvements in liver transplant outcomes over the past two decades are attributed to advances in immunosuppressive drug regimens.
- Chronic rejection and long-term graft survival continue to be significant challenges in liver transplantation.
- Adverse effects of immunosuppressants, including nephrotoxicity, hypertension, and metabolic disturbances, impact long-term patient and allograft survival.
Purpose of the Study:
- To review current immunosuppressive strategies for short- and long-term management in liver transplant recipients.
- To summarize treatment approaches for acute and chronic rejection post-liver transplantation.
- To describe complications and side effects associated with immunosuppressive therapy and its use in living-related liver transplantation.
Main Methods:
- Literature review of recent advances in immunosuppressive therapy for liver transplantation.
- Synthesis of data on the management of acute and chronic rejection.
- Analysis of complications and side effects of immunosuppressive agents.
- Review of immunosuppression protocols in living-related liver transplantation.
Main Results:
- While short-term outcomes have improved, long-term graft survival is still hampered by chronic rejection.
- Immunosuppressive agents are associated with significant side effects impacting patient health and graft longevity.
- Effective management of rejection and side effects is crucial for optimizing long-term results in liver transplant recipients.
Conclusions:
- Current immunosuppressive protocols require careful balancing of efficacy and toxicity to improve long-term liver transplant outcomes.
- Further research into novel immunosuppressive agents and strategies is needed to mitigate chronic rejection and side effects.
- Optimized immunosuppression management is essential for enhancing both graft and patient survival in liver transplantation, including living-related cases.